Literature DB >> 28842129

Leishmania tropica infected human lesions: Whole genome transcription profiling.

Nasrin Masoudzadeh1, Amir Mizbani2, Yasaman Taslimi1, Vahid Mashayekhi3, Hossein Mortazavi4, Pardis Sadeghipour1, Housein Malekafzali Ardekani1, Sima Rafati5.   

Abstract

Leishmania (L.) tropica is the main causative agent of anthroponotic cutaneous leishmaniasis (CL) in Iran. Defining the host inflammatory response in the L. tropica lesions are crucial for the development of new treatment modalities. High-throughput RNA sequencing provides a powerful method for characterization of the human gene expression profile in L. tropica lesions. Comparing the transcription profile of the L. tropica skin lesions with normal skin identified over 5000 differentially regulated genes. Gene set enrichment analysis indicated significant activation of key immunological pathways related to antigen processing and presentation. In addition, we observed a substantial upregulation of immunoglobulin genes in lesion samples, highlighting the remarkable involvement of B cells in the infection site. To our knowledge, this study is the first report to build a comprehensive picture of transcriptome changes in acute human skin lesions during infection by L. tropica.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cutaneous leishmaniasis; Gene expression profiling; High-throughput RNA sequencing; Leishmania tropica

Mesh:

Year:  2017        PMID: 28842129     DOI: 10.1016/j.actatropica.2017.08.016

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  7 in total

1.  Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis.

Authors:  Helen Ashwin; Karin Seifert; Sarah Forrester; Najmeeyah Brown; Sandy MacDonald; Sally James; Dimitris Lagos; Jon Timmis; Jeremy C Mottram; Simon L Croft; Paul M Kaye
Journal:  Wellcome Open Res       Date:  2019-01-02

2.  Transcriptional Analysis of Human Skin Lesions Identifies Tryptophan-2,3-Deoxygenase as a Restriction Factor for Cutaneous Leishmania.

Authors:  Vasco Rodrigues; Sónia André; Hasnaa Maksouri; Tarik Mouttaki; Soumiya Chiheb; Myriam Riyad; Khadija Akarid; Jérôme Estaquier
Journal:  Front Cell Infect Microbiol       Date:  2019-10-04       Impact factor: 5.293

3.  Evaluation of Immune Response and Protection Induced by V-ATPase Subunit F as DNA Vaccine Against Leishmania tropica (LCED Syrian 01) After Detection and Sequencing.

Authors:  Amira Orabi; Mohammad Maarouf; Mustafa Alammori
Journal:  Avicenna J Med Biotechnol       Date:  2020 Jan-Mar

Review 4.  In Search of Biomarkers for Pathogenesis and Control of Leishmaniasis by Global Analyses of Leishmania-Infected Macrophages.

Authors:  Patricia Sampaio Tavares Veras; Pablo Ivan Pereira Ramos; Juliana Perrone Bezerra de Menezes
Journal:  Front Cell Infect Microbiol       Date:  2018-09-19       Impact factor: 5.293

Review 5.  Biomarkers of Cutaneous Leishmaniasis.

Authors:  Fariborz Bahrami; Ali M Harandi; Sima Rafati
Journal:  Front Cell Infect Microbiol       Date:  2018-06-26       Impact factor: 5.293

6.  Editorial: Biomarkers in Leishmaniasis.

Authors:  Eugenia Carrillo; Javier Moreno
Journal:  Front Cell Infect Microbiol       Date:  2019-11-12       Impact factor: 5.293

7.  Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica.

Authors:  Nasrin Masoudzadeh; Malin Östensson; Josefine Persson; Vahid Mashayekhi Goyonlo; Christopher Agbajogu; Yasaman Taslimi; Reza Erfanian Salim; Farnaz Zahedifard; Amir Mizbani; Housein Malekafzali Ardekani; Bronwyn M Gunn; Sima Rafati; Ali M Harandi
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.